ASNB - I've mentioned many times the connection ASNB has to the "Powerwand" catheter from Access Scientific (ASNB's patented ChronoflexC). Here's why I think the Powerwand will succeed:
"Kink resistance. The POWERWAND catheter is made of ChronoFlex®C—exclusively available on the POWERWAND—which, owing to a proprietary process, makes it virtually kink-free in almost all clinical situations.
"Greater patient satisfaction, due to extended dwell time and blood draw-ability. In a published, peer-reviewed study (JAVA, Spring 2012), patients rated their satisfaction with the device at 98.7%. By comparison, only a minority of patients (42%) reports being satisfied about their experience with other kinds of peripheral IVs."
"Finally, there is the new CMS incentive—under Medicare’s “value-based purchasing” program—to increase patient satisfaction with the inpatient experience. Hospitals showing “better than average” or “most improved” patient satisfaction are eligible for Medicare bonus payments from a pool of $850 million."
Access Scientific, Inc. is Acquired by Endeavour Capital
SAN DIEGO, CA. (November 6, 2012) — Access Scientific, Inc. (ASI), a leading provider of over-wire vascular access technology, announced today that they have completed an acquisition agreement with Endeavour Capital.
"We are very pleased with the traction POWERWAND has seen in the marketplace. The technology has the potential to significantly improve the patient’s hospital experience by requiring a single needlestick for vascular access throughout the length of stay. Endeavour’s investment will allow us to increase our efforts to bring this groundbreaking vascular access technology to the marketplace,” stated Steve Bierman, M.D., CEO of Access Scientific.
“Access Scientific’s products provide clinical differentiation within the vascular access market. We believe the technology is impactful to both clinicians and patients, and we are excited to provide the growth capital necessary to support ASI’s growth and success,” said Mark Dorman, Endeavour Capital Managing Director."
http://www.the-wand.com/pdf/PR-0021_A.pdf
A good read here:
http://www.infectioncontroltoday.com/articles/2013/03/midline-catheters-an-essential-tool-in-clabsi-reduction.aspx
"Kink resistance. The POWERWAND catheter is made of ChronoFlex®C—exclusively available on the POWERWAND—which, owing to a proprietary process, makes it virtually kink-free in almost all clinical situations.
"Greater patient satisfaction, due to extended dwell time and blood draw-ability. In a published, peer-reviewed study (JAVA, Spring 2012), patients rated their satisfaction with the device at 98.7%. By comparison, only a minority of patients (42%) reports being satisfied about their experience with other kinds of peripheral IVs."
"Finally, there is the new CMS incentive—under Medicare’s “value-based purchasing” program—to increase patient satisfaction with the inpatient experience. Hospitals showing “better than average” or “most improved” patient satisfaction are eligible for Medicare bonus payments from a pool of $850 million."
Access Scientific, Inc. is Acquired by Endeavour Capital
SAN DIEGO, CA. (November 6, 2012) — Access Scientific, Inc. (ASI), a leading provider of over-wire vascular access technology, announced today that they have completed an acquisition agreement with Endeavour Capital.
"We are very pleased with the traction POWERWAND has seen in the marketplace. The technology has the potential to significantly improve the patient’s hospital experience by requiring a single needlestick for vascular access throughout the length of stay. Endeavour’s investment will allow us to increase our efforts to bring this groundbreaking vascular access technology to the marketplace,” stated Steve Bierman, M.D., CEO of Access Scientific.
“Access Scientific’s products provide clinical differentiation within the vascular access market. We believe the technology is impactful to both clinicians and patients, and we are excited to provide the growth capital necessary to support ASI’s growth and success,” said Mark Dorman, Endeavour Capital Managing Director."
http://www.the-wand.com/pdf/PR-0021_A.pdf
A good read here:
http://www.infectioncontroltoday.com/articles/2013/03/midline-catheters-an-essential-tool-in-clabsi-reduction.aspx
Recent NORD News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2026 07:42:23 PM
- Nordicus Partners Corporation Corporate Update • GlobeNewswire Inc. • 02/06/2026 04:55:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/04/2026 06:28:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2026 08:30:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 02:00:47 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 06:08:32 PM
- NoviThera has initiated the first efficacy animal studies • GlobeNewswire Inc. • 11/13/2025 04:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/28/2025 08:05:16 PM
- Orocidin’s QR-01 Shows Positive Results in Treating Periodontitis in the treatment of experimental periodontitis in Wistar rats. • GlobeNewswire Inc. • 10/22/2025 01:00:00 PM
- Orocidin develops novel cGMP manufacturing process in collaboration with Syngene • GlobeNewswire Inc. • 10/20/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/14/2025 01:00:24 PM
- Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 10/14/2025 01:00:23 PM
- Nordicus Partners Corporation Announces The Formation Of A New Company, NoviThera ApS • GlobeNewswire Inc. • 10/03/2025 08:38:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2025 01:43:00 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2025 10:07:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2025 06:45:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2025 01:38:25 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/05/2025 06:43:13 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/29/2025 07:21:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2025 12:01:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/01/2025 07:55:13 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 06/27/2025 01:15:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2025 01:00:36 PM

